EXAGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.412 USD | +0.15% |
|
+3.07% | -29.04% |
| 26/04 | Exagen Inc. Announces Changes in Board of Directors | CI |
| 18/03 | Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Exagen Inc.
ee0bcc8effaee83f2bc12.lG4NQeA43ZhMAUSzpOAzo-zwr2yxsMsC9EhPfmzPDbo.oxteLpFr7c4FdDbknZBg2qTG7SWFxvpIgAsVEj__f-2sQ1ts0WyE7AteNw~2aca3b012c1b78f65b849631de50eb42
Upcoming events on Exagen Inc.
Past events on Exagen Inc.
| 20/03/2024 11:00 pm | KeyBanc Life Sciences & MedTech Forum |
| 18/03/2024 06:00 pm | Q4 2023 Earnings Call |
| 18/03/2024 05:30 pm | Q4 2023 Earnings Release |
| 13/02/2024 | BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
| 16/11/2023 08:00 pm | Canaccord Genuity MedTech Diagnostics and Digital Health and Services Forum |
| 14/11/2023 10:30 pm | American College of Rheumatology Conference - Abstract No: 2273 |
| 14/11/2023 03:00 am | Q3 2023 Earnings Call |
| 14/11/2023 02:35 am | Q3 2023 Earnings Release |
| 12/11/2023 10:30 pm | American College of Toxicology Meeting - Abstract No: 0576 |
| 12/11/2023 10:30 pm | American College of Toxicology Meeting - Abstract No: 0575 |
| 12/11/2023 10:30 pm | American College of Toxicology Meeting - Abstract No: 0557 |
| 12/11/2023 10:30 pm | American College of Toxicology Meeting - Abstract No: 0099 |
| 26/09/2023 06:15 pm | Cantor Global Healthcare Conference |
| 10/08/2023 12:30 am | Canaccord Genuity Growth Conference |
| 07/08/2023 06:00 pm | Q2 2023 Earnings Call |
| 07/08/2023 05:30 pm | Q2 2023 Earnings Release |
| 09/06/2023 08:30 pm | Annual General Meeting |
| 08/06/2023 12:30 am | William Blair Growth Stock Conference |
| 16/05/2023 02:00 am | Q1 2023 Earnings Call |
| 16/05/2023 01:35 am | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 40,4 40,5 -0.36% | 42,0 40,0 4.98% | 48,3 47,3 2.04% | 45,6 41,8 9.13% | 52,5 50,3 4.42% | 54,2 |
|
EBITDA Million USD | Released Forecast Spread | -8,71 -9,50 8.34% | -14,6 -16,3 10.19% | -23,1 -24,1 4.07% | -39,0 -43,3 10.01% | -20,7 -20,0 -3.35% | -17,0 |
|
EBIT Million USD | Released Forecast Spread | -9,30 -10,5 11.61% | -15,2 -16,9 9.94% | -24,1 -25,4 5.32% | -40,5 -44,6 9.04% | -22,8 -24,7 7.72% | -21,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,0 -13,8 12.95% | -16,8 -18,2 7.92% | -26,7 -27,9 4.22% | -47,7 -46,6 -2.29% | -23,7 -26,1 9.19% | -24,1 |
|
Net income Million USD | Released Forecast Spread | -30,3 -13,8 -119.41% | -16,7 -18,1 7.96% | -26,9 -27,9 3.59% | -47,4 -46,6 -1.69% | -23,7 -25,9 8.62% | -24,3 |
|
EPS USD | Released Forecast Spread | -8,46 -1,96 -331.63% | -1,32 -1,43 7.85% | -1,68 -1,74 3.67% | -2,77 -2,70 -2.67% | -1,34 -1,47 9.09% | -1,36 |
| Announcement Date | 25/03/20 | 16/03/21 | 22/03/22 | 20/03/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 12,7 11,7 8.3% | 10,4 10,00 3.96% | 8,96 12,0 -25.52% | 14,7 9,13 61.29% | 12,8 8,72 47.21% | 11,2 9,40 19.47% | 14,1 10,9 29.36% | 13,4 10,3 29.83% | 13,8 11,6 19.07% | 13,1 | 13,3 | 13,6 | 14,2 | 14,2 |
|
EBITDA Million USD | Released Forecast Spread | -5,96 -6,98 14.52% | -9,40 -9,33 -0.76% | -12,4 -8,93 -38.87% | -7,38 -12,0 38.4% | -8,47 -12,5 32.42% | -7,15 -8,27 13.47% | -4,41 -7,70 42.7% | -4,47 -7,75 42.39% | -4,64 -6,80 31.78% | -4,60 | -4,58 | -4,25 | -3,68 | -3,90 |
|
EBIT Million USD | Released Forecast Spread | -6,25 -7,62 17.93% | -9,68 -9,74 0.63% | -12,7 -9,08 -39.96% | -7,82 -12,4 36.96% | -8,99 -13,0 30.88% | -7,71 -9,22 16.42% | -4,92 -8,42 41.63% | -5,07 -7,88 35.63% | -5,15 -7,08 27.25% | -5,56 | -5,54 | -5,34 | -4,88 | -5,30 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,88 -8,05 14.56% | -10,3 -10,3 0.51% | -13,3 -9,65 -37.92% | -8,10 -13,1 38.08% | -14,6 -13,6 -7.62% | -7,69 -9,78 21.35% | -5,01 -8,73 42.54% | -5,42 -8,15 33.56% | -5,54 -7,68 27.82% | -6,30 | -6,30 | -6,10 | -5,50 | -5,90 |
|
Net income Million USD | Released Forecast Spread | -7,05 -8,05 12.39% | -10,3 -10,3 0.51% | -13,3 -9,65 -37.92% | -8,10 -13,1 38.08% | -14,4 -13,6 -5.54% | -7,69 -9,78 21.35% | -5,01 -8,73 42.54% | -5,42 -8,15 33.56% | -5,57 -7,68 27.39% | -6,30 | -6,30 | -6,10 | -5,50 | -5,90 |
|
EPS USD | Released Forecast Spread | -0,42 -0,46 9.09% | -0,60 -0,61 1.32% | -0,78 -0,57 -37.81% | -0,47 -0,76 38.16% | -0,83 -0,76 -9.21% | -0,44 -0,56 21.15% | -0,28 -0,49 42.86% | -0,31 -0,46 33.19% | -0,31 -0,43 28.57% | -0,36 | -0,36 | -0,34 | -0,31 | -0,32 |
| Announcement Date | 22/03/22 | 11/05/22 | 04/08/22 | 14/11/22 | 20/03/23 | 15/05/23 | 07/08/23 | 13/11/23 | 18/03/24 | - | - | - | - | - |
More events
Past sector events for Exagen Inc.
| 26/04/2024 05:00 pm | HCA HEALTHCARE, INC.: Q1 2024 Earnings Release |
| 26/04/2024 04:58 pm | PT MEDIKALOKA HERMINA TBK: Q1 2024 Earnings Release |
| 26/04/2024 11:15 am | MEDICOVER AB: Q1 2024 Earnings Release |
| 26/04/2024 | NEW JOURNEY HEALTH TECHNOLOGY GROUP CO.,LTD: Q1 2024 Earnings Release |
| 26/04/2024 01:33 am | ACCOLADE, INC.: Q4 2024 Earnings Release |
| 25/04/2024 04:28 pm | LABORATORY CORPORATION OF AMERICA HOLDINGS: Q1 2024 Earnings Release |
| 25/04/2024 06:39 am | BUMRUNGRAD HOSPITAL: Q1 2024 Earnings Release |
| 25/04/2024 | MEINIAN ONEHEALTH HEALTHCARE HOLDINGS CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 01:46 am | UNIVERSAL HEALTH SERVICES, INC.: Q1 2024 Earnings Release |
| 25/04/2024 01:45 am | CHEMED CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- XGN Stock
- Calendar Exagen Inc.
